HANDOK Inc. (KRX:002390)

Market Cap	136.28B -12.1%
Revenue (ttm)	535.14B +5.5%
Net Income	-2.15B
EPS	-162.00
Shares Out	12.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (1.85%)
Ex-Dividend Date	Feb 26, 2026

Volume	13,751
Average Volume	13,421
Open	10,850
Previous Close	10,790
Day's Range	10,410 - 10,860
52-Week Range	9,990 - 14,250
Beta	0.39
RSI	45.41
Earnings Date	May 13, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 940
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2025, HANDOK's revenue was 535.14 billion, an increase of 5.48% compared to the previous year's 507.36 billion. Losses were -2.15 billion, -95.90% less than in 2024.